REFERENCES
  1. Bandadi F-Z, Raiss C, Moustachi A, Lyagoubi M, Aoufi S. Forty cases of neuromeningeal cryptococcosis diagnosed at the mycology parasitology department of the Ibn Sina hospital in Rabat, over a 21-year period. Pan Afr Med J. 2019;33:249. doi:10.11604/pamj.2019.33.249.18011
  2. Gbané-Koné M, Ouali B, Mègne E, et al. Cryptococcose neuroméningée et tuberculose osseuse chez un immunocompétent: un cas. Pan Afr Med J. 2015;20:109. doi:10.11604/pamj.2015.20.109.6055
  3. Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus infected persons. J Infect Dis. 1999;179(2):449-454. doi:10.1086/314606
  4. Gangneux J-P, Bougnoux M-E, Hennequin C, et al. An estimation of burden of serious fungal infections in France. J Mycol Méd. 2016;26(4):385-390. doi:10.1016/j.mycmed.2016.11.001
  5. Kambugu A, Meya DB, Rhein J, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46(11):1694-1701. doi:10.1086/587667
  6. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin infect Dis. 2000;30(4):710-718. doi:10.1086/313757
  7. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization, 2007 [online]. Available on: https://apps.who.int/iris/handle/10665/43699 [accessed on 3 march 2022]
  8. Revest M, Decaux O, Frouget T, et al. Cryptococcal infections in non-HIV infected patients. Study of four cases and review of literature. Rev Med Interne. 2006;27(3):203-208. doi:10.1016/j.revmed.2005.11.011
  9. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis. 2006;10(1):72-78. doi:10.1016/j.ijid.2004.12.004
  10. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS–100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995;8(4):515-548. doi:10.1128/CMR.8.4.515
  11. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. Q J Med. 2000;93(4):245-251. doi:10.1093/qjmed/93.4.245
  12. Chuck SL, Sande MA. Infections with cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989;321(12):794-799. doi :10.1056/NEJM198909213211205
  13. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690-699. doi:10.1086/322597
  14. Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore). 2001;80(5):308-312. doi:10.1097/00005792-200109000-00004
  15. Assogba K, Belo M, Wateba MI, et al. Neuromeningeal cryptococcosis in sub-Saharan Africa: Killer disease with sparse data. J Neurosci Rural Pract. 2015;6(2):221-224. doi:10.4103/0976-3147.153231